Exelixis
Price & Volume
Stats
See more52W Range | $33.75-$61.14 |
Market Cap | $14.8B |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $2.4B |
Revenue Growth (YoY) | 10.6% |
Gross Profit (12 Mos) | $2.3B |
Diluted EPS | $3.17 |
News
See moreYahoo Finance • 9 days ago
These IBD 50 Stocks Are Stalled. That Could Be A Good Thing.
Yahoo Finance • 10 days ago
Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks
Yahoo Finance • 26 days ago
Exelixis Eyes Zanza Launch as CABOMETYX Growth Faces NET Ramp Hurdle
Yahoo Finance • 30 days ago
Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay
About
CEO | Dr. Michael M. Morrissey Ph.D. |
CFO | Mr. Christopher J. Senner |
Address | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,077 |